Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EW4815 / 2||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Dyspnoea, Cardiac death, Breath sounds abnormal
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: MOVICOL [MACROGOL 3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE]; FURESIS; CITALOPRAM; LYRICA; MONTELUKAST; PANADOL FORTE [PARACETAMOL]
Preexisting Conditions: Medical History/Concurrent Conditions: Alzheimer''s disease; Atrial fibrillation; Coronary artery disease; Disability; Leg amputation; Loss of personal independence in daily activities; Lower limb ischaemia; Shortness of breath (Episodes of shortness of breath, swelling in the past while living in an assisted living facility); Swelling (Episodes of shortness of breath, swelling in the past while living in an assisted living facility)
Diagnostic Lab Data:
CDC 'Split Type': FIPFIZER INC2021572963
Write-up: Cardiac death; Coarse breath sounds; Dyspnoea; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority (RA)-WEB FI-FIMEA-20212550. An 89-year-old male patient received the second dose of BNT162B2 (COMIRNATY, lot number: EW4815 and expiration date not provided), via intramuscular, on 29Apr2021 (at the age of 89-year-old), at single dose, for COVID-19 immunization. Medical history included patient was multi-disabled, had been in 24-hour care for over a year, advanced Alzheimer''s disease, coronary artery disease, atrial fibrilation, acute lower limb ischaemia from Nov2019, left thigh amputation, restricted to hospital transfers. Patient had episodes of shortness of breath, swelling in the past while living in an assisted living facility. Concomitant medications included macrogol 3350, potassium chloride, sodium bicarbonate, sodium chloride (MOVICOL); furosemide (FURESIS); citalopram; pregabalin (LYRICA); montelukast; and paracetamol (PANADOL FORTE). Patient previously took first dose of BNT162B2 (COMIRNATY, lot number: EJ6134 and expiration date not provided), via unknown route of administration, on unknown date, at single dose, for COVID-19 immunization. The patient received vaccine on 29Apr2021, and later that day patient experienced cardiac death (death), coarse breath sounds (death), and dyspnoea (death). Patient had an increase in breathlessness, which was treated symptomatically (ventoline oral solution) and the dose of furosemide (FURESIS) was increased. The following day, as the symptoms persisted, an additional oral cortisone course was started, as there had been intermittent episodes of obstruction in the past, although the patient had no previous diagnosis of lung disease, but was no longer in a good enough overall health to warrant further investigation. With changes in medication, the patient''s condition improved and on 03May2021 the patient was already back to normal. On 05May2021 evening developed shortness of breath and wheezing, during the night patient received symptomatic medication, on 06May2021 morning patient exitus. The death was thought to be cardiac-related and a death certificate was issued. The situation has not yet been discussed with the infectious disease doctor, the coronary vaccine and death have a time link but no causal link was established, filing an incident report was nevertheless recommended. It was reported that it can''t be directly concluded that the drug harm was fatal, and on the other hand, the recovery from the possible harm remains a question mark. Therapeutic measures were taken as a result of events coarse breath sounds and dyspnoea. The outcome of the events were fatal. The patient died on 06May2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Cardiac death; coarse breath sounds; dyspnoea
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166